Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study (CC-POCA)
Primary Purpose
Cardiac Arrest
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
REBOA catheter
Sponsored by
About this trial
This is an interventional treatment trial for Cardiac Arrest focused on measuring REBOA, ROSC, Cardiac arrest
Eligibility Criteria
Inclusion Criteria:
- - Patients aged 18-75 years old
Suspected reversible cause of cardiac arrest (except for trauma), with one of any of the following prognostic signs30
- Reactive pupils
- Agonal breathing
- EtCO2>10 mmHg
- Any cardiac activity on bedside echocardiogram
- Body habitus accommodating automated Lund University Cardiac Arrest System (LUCAS)
- Level of care includes CPR, or unable to obtain level of care (if possible, validate with relative)
- More than 15 minutes of ACLS with no ROSC or more than 30 minutes of BLS with no ROSC
Exclusion Criteria:
Transfer accepted for ECPR
- History of severe dementia
- Advance Medical Directives against resuscitation
- History of aortic pathology or surgery
- LUCAS not compatible with the patient's body habitus
- Pregnancy
- Any illness resulting in loss of independent living capacity
- Severe cardiopulmonary disease
- Aortic dissection, aortic aneurysm, tension pneumothorax or tamponade seen on TEE/TTE
- Strangulation
- Suspected intracerebral hemorrhage
- Accidental hypothermia
- More than 60 minutes of resuscitation
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
interventional
Arm Description
20 patients with inclusion criteria and without exclusion criteria will be entered in the interventional arm attempting to use REBOA during non-traumatic cardiac arrest.
Outcomes
Primary Outcome Measures
success rate and time of REBOA inflation during non-traumatic arrest in a community hospital
● Feasibility of intra-arrest REBOA catheter placement and zone 1 inflation in NTCA in a community hospital setting
Secondary Outcome Measures
blood pressure
Systolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
Diastolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
ETCO2
(Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
cerebral saturation
(Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
ROSC
return of spontaneous circulation
TEE-guided REBOA positioning
success rate of determining REBOA placement by trans esophageal echocardiography
7 day survival
follow up to 7 days
Full Information
NCT ID
NCT05326789
First Posted
March 28, 2022
Last Updated
April 6, 2022
Sponsor
Ciusss de L'Est de l'Île de Montréal
1. Study Identification
Unique Protocol Identification Number
NCT05326789
Brief Title
Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study
Acronym
CC-POCA
Official Title
Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 1, 2022 (Anticipated)
Primary Completion Date
May 1, 2023 (Anticipated)
Study Completion Date
August 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ciusss de L'Est de l'Île de Montréal
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Our general objective, during this study, is to evaluate the feasibility and potential physiological benefits of using REBOA (resuscitative endovascular balloon occlusion of the aorta) CPR (cardiopulmonary resuscitation) for patients presenting with a cardiac arrest to a community hospital. This would represent the first step for doing a larger, randomized clinical trial on the use of REBOA in non-traumatic cardiac arrest.
Detailed Description
Primary objective: Validate the feasibility of using REBOA in a community hospital setting during cardiac arrest as an adjunct to ACLS (advances cardiac life support) . This will be done by measuring time to REBOA placement and successful inflation. Furthermore, we will also document any REBOA related complications.
Secondary objectives: Evaluate the potential physiological benefits of REBOA for human subjects in NTCA (non traumatic cardiac arrest) that are not responding to standard ACLS.
Study Design and Methodology Trial design The trial is a single-center, single-arm, open (unblinded), feasibility, experimental study.
Study Duration The study is expected to begin in winter 2022 and last approximately 12 months. Population studied The population studied will be patients in non-traumatic cardiac arrest at Santa Cabrini Hospital, aged 18-75 years old.
Patients presenting with a witnessed cardiac arrest (out of hospital cardiac arrest (OHCA) or in hospital cardiac arrest (IHCA)) and in which ACLS was performed for at least 15 minutes or BLS for at least 30 minutes and for no more than 60 minutes will be evaluated for eligibility to participate in the study.
Number of patients 20
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest
Keywords
REBOA, ROSC, Cardiac arrest
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
single-center, single-arm, open (unblinded), feasibility, experimental study
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
interventional
Arm Type
Experimental
Arm Description
20 patients with inclusion criteria and without exclusion criteria will be entered in the interventional arm attempting to use REBOA during non-traumatic cardiac arrest.
Intervention Type
Device
Intervention Name(s)
REBOA catheter
Other Intervention Name(s)
resuscitative endovascular balloon occlusion of the aorta
Intervention Description
balloon occlusion of the aorta during cardiac arrest to optimize coronary and cerebral perfusion.
Primary Outcome Measure Information:
Title
success rate and time of REBOA inflation during non-traumatic arrest in a community hospital
Description
● Feasibility of intra-arrest REBOA catheter placement and zone 1 inflation in NTCA in a community hospital setting
Time Frame
1 year
Secondary Outcome Measure Information:
Title
blood pressure
Description
Systolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
Diastolic blood pressure (Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
Time Frame
0-15 min per study over a year
Title
ETCO2
Description
(Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
Time Frame
0-15 min per study over a year
Title
cerebral saturation
Description
(Pre balloon occlusion, Post balloon occlusion 30sec, 1min, 5min, 10min, 15min)
Time Frame
0-15 min per study over a year
Title
ROSC
Description
return of spontaneous circulation
Time Frame
0-30 min per study over a year
Title
TEE-guided REBOA positioning
Description
success rate of determining REBOA placement by trans esophageal echocardiography
Time Frame
5 minutes per study over 1 year
Title
7 day survival
Description
follow up to 7 days
Time Frame
7 days over a year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Patients aged 18-75 years old
Suspected reversible cause of cardiac arrest (except for trauma), with one of any of the following prognostic signs30
Reactive pupils
Agonal breathing
EtCO2>10 mmHg
Any cardiac activity on bedside echocardiogram
Body habitus accommodating automated Lund University Cardiac Arrest System (LUCAS)
Level of care includes CPR, or unable to obtain level of care (if possible, validate with relative)
More than 15 minutes of ACLS with no ROSC or more than 30 minutes of BLS with no ROSC
Exclusion Criteria:
Transfer accepted for ECPR
History of severe dementia
Advance Medical Directives against resuscitation
History of aortic pathology or surgery
LUCAS not compatible with the patient's body habitus
Pregnancy
Any illness resulting in loss of independent living capacity
Severe cardiopulmonary disease
Aortic dissection, aortic aneurysm, tension pneumothorax or tamponade seen on TEE/TTE
Strangulation
Suspected intracerebral hemorrhage
Accidental hypothermia
More than 60 minutes of resuscitation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Philippe Rola, MD
Phone
15142177892
Email
philipperola@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Lawrence Leroux, MD
Phone
15148894644
Email
lawrence.leroux.1@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Coronary and Cerebral Perfusion Optimization in Cardiac Arrest: A Feasibility and Physiological Study
We'll reach out to this number within 24 hrs